Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
William Aird: Anemia of Inflammation Not Just a Trade-Off but a Possible Compensation
William Aird/X
Apr 12, 2026, 13:42

William Aird: Anemia of Inflammation Not Just a Trade-Off but a Possible Compensation

William Aird, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:

”Anemia of inflammation: trade – off or adaptation?

We usually think of anemia of inflammation as a cost.

Iron is sequestered to limit microbial growth, and red cell production falls as a consequence.

But there may be another way to look at it.

The acute phase response increases plasma viscosity, driven in part by fibrinogen.
At the same time, hematocrit falls.

Since hematocrit is a major determinant of whole-blood viscosity, even a modest reduction may offset the rheologic effects of inflammation.

In other words:

  • Inflammation thickens the plasma.
  • Anemia thins the suspension.

Two observations are at least consistent with this idea:

  • In critical care, restrictive transfusion strategies (hemoglobin ~7 g/dL) perform as well as, or better than, more liberal approaches.
  • And in anemia of inflammation, hemoglobin levels tend to plateau rather than fall indefinitely, often remaining in the 7–10 g/dL range unless another process is present.

There appears to be a floor.

Not necessarily just a trade-off.
Possibly a compensation.”

Other posts featuring William Aird on Hemostasis Today.

anemia of inflammation Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine thrombosis William Aird
NewsFeed